「实战经验分享」真实世界之ALK重排诊疗( 七 )
[8] Mok T, Peters S, Camidge DR. Patients with ALK IHC-positive/fish-negative NSCLC benefit from ALK TKI treatment: response data from the global ALEX trial. Presented at: the IASLC 18th World Conference on Lung Cancer; October 15-18; Yokohama, Japan. Poster MA 07.01.
[9] CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib. Cancer Biol Ther. 2018 Oct 1:1-5.
[10] Comprehensive Genomic Profiling Identifies a Subset of Crizotinib-Responsive ALK-Rearranged Non-Small Cell Lung Cancer Not Detected by Fluorescence In Situ Hybridization. The Oncologist. 2016;21(6):762-770.
[11] www.nccn.org/patients.
[12] Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update. J Clin Oncol 2018, 36:911-919.
- 养生|钟南山的养生经:健康长寿的秘诀,其实就简单3点,分享给你
- 李湘减肥成功了?大方分享“减肥秘籍”,方法或值得学习
- 好物分享丨减肥还管不住嘴?减脂零食快看一看,嘴馋星人必备
- 今日份的冷知识也是很有趣,这不得分享一波?
- 98岁肝胆科之父:研究乙肝60载,分享3条“实战方”
- 尿酸高,如何让尿酸排出体外?医生分享3个办法,或许值得一试
- 腹痛患者偶然诊断十二指肠贾第虫病|病例分享
- 个人经验:我如何找到完美的睡眠模式并优化我的生活
- 还在凭经验?科室主任和护士长要这样当
- 多案例分享:如何规范撰写统计分析方法